HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Glutathione-sensitive RGD-poly(ethylene glycol)-SS-polyethylenimine for intracranial glioblastoma targeted gene delivery.

AbstractBACKGROUND:
Reductively reversible and hydrolytically degradable cationic polymers have been used as gene delivery systems. The present study aimed to enhance the low transfection efficiency caused by PEGylation by taking advantage of a nonviral vector containing a disulfide linkage.
METHODS:
The novel reducible targeted gene vector c(RGDyK)-poly(ethylene glycol)-SS-polyethylenimine (RGD-PEG-SS-PEI), representing a combination of RGD-PEG with PEI through a disulfide linkage, was synthesized and its reduction-sensitivity was tested in the presence of glutathione. The RGD-PEG-SS-PEI/pDNA complexes were formed and their stability was evaluated by agarose gel electrophoresis in both phosphate-buffered saline and Dulbecco's modified Eagle's medium with 10% serum. In vitro transfection efficiency and cell viability assay of the different polymers was performed for U87 cells using pEGFP-N2 and pGL4.2 reporter gene systems. RGD-PEG-SS-PEI/pDsRED-N1 and RGD-PEG-PEI/pDsRED-N1 complexes were injected intravenously into the U87 cell-bearing nude mice via their tail vein to investigate in vivo gene expression.
RESULTS:
RGD-PEG-SS-PEI has been synthesized successfully and its reduction-sensitivity was confirmed in the presence of glutathione. The RGD-PEG-SS-PEI/pDNA complexes demonstrated good stability in both conditions. In comparison with mPEG-PEI/pDNA for gene delivery, the RGD-PEG-SS-PEI/pDNA complex provided improved levels of transfection efficiency and reduced cytotoxicity when tested in U87 cells in vitro, and also enhanced levels of gene expression in the brains of intracranial U87 glioblastoma-bearing mice as demonstrated using dsRed gene transfer and bioimaging in vivo.
CONCLUSIONS:
The results of the present study suggest that RGD-PEG-SS-PEI represents a promising candidate for further study in glioblastoma and combined gene therapies.
AuthorsYang Lei, Jing Wang, Cao Xie, Ernst Wagner, Weiyue Lu, Ying Li, Xiaoli Wei, Jibin Dong, Min Liu
JournalThe journal of gene medicine (J Gene Med) 2013 Aug-Sep Vol. 15 Issue 8-9 Pg. 291-305 ISSN: 1521-2254 [Electronic] England
PMID24038955 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 John Wiley & Sons, Ltd.
Chemical References
  • Disulfides
  • Luminescent Proteins
  • RGD-poly(ethylene glycol)-SS-polyethylenimine
  • enhanced green fluorescent protein
  • fluorescent protein 583
  • Green Fluorescent Proteins
  • Polyethylene Glycols
  • Polyethyleneimine
  • Glutathione
Topics
  • Animals
  • Brain Neoplasms (pathology, therapy)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Disulfides (chemistry)
  • Genes, Reporter
  • Genetic Therapy
  • Glioblastoma (pathology, therapy)
  • Glutathione (chemistry)
  • Green Fluorescent Proteins (biosynthesis, genetics)
  • Humans
  • Luminescent Proteins (biosynthesis, genetics)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Nanoparticles (chemistry, toxicity)
  • Neoplasm Transplantation
  • Oxidation-Reduction
  • Particle Size
  • Polyethylene Glycols (chemistry, toxicity)
  • Polyethyleneimine (analogs & derivatives, chemistry, toxicity)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: